Summit Therapeutics Inc. - COM (SMMT)

Historical Holders from Q3 2020 to Q3 2025

Symbol
SMMT on Nasdaq
Type / Class
Equity / COM
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
103M
Holdings value
$2.12B
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
228
Number of buys
126
Number of sells
-108
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of Summit Therapeutics Inc. - COM (SMMT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 103M $2.12B +$101M $20.66 228
2025 Q2 97.8M $2.08B +$34.1M $21.28 225
2025 Q1 97.7M $1.89B +$89M $19.29 199
2024 Q4 92.6M $1.65B +$118M $17.85 194
2024 Q3 84.5M $1.85B +$298M $21.90 164
2024 Q2 72.2M $563M +$186M $7.80 118
2024 Q1 49.7M $206M +$72.5M $4.14 102
2023 Q4 32.3M $84.4M +$2.19M $2.61 93
2023 Q3 32.3M $60.4M -$5.14M $1.87 91
2023 Q2 34.9M $87.6M +$36.4M $2.51 96
2023 Q1 21.1M $37M +$21.8M $1.75 86
2022 Q4 8.1M $34.5M +$22.6M $4.25 57
2022 Q3 3.17M $3.77M -$5.11M $1.19 37
2022 Q2 8.46M $8.46M -$4.23M $1.00 33
2022 Q1 10.9M $26.8M -$300K $2.45 44
2021 Q4 11M $29.7M +$54.2K $2.69 49
2021 Q3 10.9M $54.8M -$944K $5.01 50
2021 Q2 11M $82.4M +$14.1M $7.46 52
2021 Q1 9.28M $54.5M +$1.36M $5.87 36
2020 Q4 9.06M $42.6M +$2.51M $4.70 31
2020 Q3 7.75M $26.8M +$26.8M $3.44 15